Genotypic Distribution and the Epidemiology of Multidrug Resistant Tuberculosis in Upper Northern Thailand

Author:

Saikaew Sukanya,Thongprachum AksaraORCID,Pongsararuk Rodjana,Thanraka Aungkana,Kunyanone Naowarat,Chaiyasirinroje Boonchai,Luangsook Praphan,Butr-Indr Bordin,Phunpae Ponrut,Wattananandkul UsaneeORCID

Abstract

The epidemiology and genotypes of multidrug-resistant tuberculosis (MDR-TB), a global public health threat, remain limited. The genotypic distribution and factors associated with MDR-TB in upper northern Thailand between 2015 and 2019 were investigated. The DNA sequencing of rpoB, katG, and inhA promoter of 51 multidrug-resistant Mycobacterium tuberculosis isolates revealed nine patterns of the rpoB gene mutation distributed in seven provinces. The S531L mutation was the most common mutation in all provinces. The rpoB mutation in Chiang Rai, Chiang Mai, and Lampang was highly diverse compared to other areas. Here, the mutation profiles that have yet to be reported in northern Thailand (H526P, Q513P, and H526C) were detected in Chiang Rai province. The S315T katG mutation was the most common genotype associated with INH resistance, especially in Chiang Mai and Lampang. Further analysis of data from 110 TB patients (42 MDR-TB and 68 drug-susceptible TB) revealed that <60 years of age was a significant factor associated with MDR-TB (OR = 0.316, 95% CI 0.128–0.784, p = 0.011) and ≥60 years of age was a significant factor associated with the S315T katG-mutation (OR = 8.867, 95% CI 0.981–80.177, p = 0.047). This study highlighted the necessity for continuous surveillance and risk factor monitoring for effective control of MDR-TB.

Funder

Graduate Study Development Grant, National Re-search Council of Thailand

Government Budget grant, NRCT

Health Systems Research Institute (HSRI) under the Thailand Grand Challenge Research Program

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology

Reference43 articles.

1. World Health Organization (2022, November 18). Global Tuberculosis Report. Available online: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022.

2. World Health Organization (2022, August 01). Global Tuberculosis Report. Available online: https://www.who.int/publica-tions/i/item/9789240013131.

3. World Health Organization (2022, August 01). Global Tuberculosis Report. Available online: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2021.

4. Center of Epidemiological Information (2022, August 10). Bureau of Epidemiology. Reported Cases and Deaths by Province and by Month Thailand 2561(2018). Tuberculosis. Available online: https://apps-doe.moph.go.th/boeeng/download/AW_Annual_Mix%206212_14_r1.pdf.

5. Strategy and Evaluation Group in Bureau of Tuberculosis (2022, August 01). Tuberculosis Situation in Thailand. Available online: https://www.tbthailand.org/download/สถานการณ์วัณโรคของประเทศไทย 10 พย. 60 final 1.pdf.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3